Overview

A Study of HS-20094 in Chinese Adults with Overweight or Obesity

Status:
RECRUITING
Trial end date:
2026-02-27
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the Efficacy and safety of HS-20094 in overweight and obese patients. The study will last up to approximately 52 weeks.
Phase:
PHASE3
Details
Lead Sponsor:
Jiangsu Hansoh Pharmaceutical Co., Ltd.